Using a large Japanese real‐world database, we examined antidiabetic drug selection in first and second therapy stratified by renal function and study period. The earlier initiation of SGLT2 inhibitors and GLP‐1 receptor agonists increased over time, particularly in second therapy, with prescribing patterns increasingly aligned across renal function ...
Masashi Kubota +2 more
wiley +1 more source
Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in chronic kidney disease: an updated meta-analysis of randomized controlled trials. [PDF]
Muhammad Daniyal S +13 more
europepmc +1 more source
Pharmacokinetics and pharmacodynamics of desoxycorticosterone pivalate in dogs with hypoadrenocorticism. [PDF]
Langlois DK +10 more
europepmc +1 more source
Established and emerging pharmacologic options and unmet needs in HFpEF and HFmrEF. [PDF]
Sauer AJ, Ter Maaten JM, Savarese G.
europepmc +1 more source
Steroids:Modulators of inflammation and immunity [PDF]
Chapman, Karen E, Odermatt, Alex
core +1 more source
The Role of Aldosterone in Detecting Resistance-Driven Hypoaldosteronism and Deficit-Driven Hypoaldosteronism. [PDF]
Ruiz-Sánchez JG +5 more
europepmc +1 more source
A Rare Encounter: Severe Hypertension and Hypokalemia Due to an Apparent Mineralocorticoid Excess [PDF]
Kamel El-Reshaid, Emad Abdullah
openalex +1 more source
Management of chronic kidney disease in a 65-year-old man with diabetes. [PDF]
Dubrofsky L, Cherney DZI, Odutayo A.
europepmc +1 more source

